参考文献/References:
[1]张丽,张蕾,李娜,等.妊娠期高血压患者血清circ-0002348和circ-0002814表达水平及其与妊娠结局相关性研究[J].陕西医学杂志,2025,54(2):197-200,204.
[2]高晓明.血清ESM-1、TM和sVCAM-1水平对妊娠高血压患者不良妊娠结局的诊断价值[J].检验医学与临床,2022,19(5):648-652.
[3]谢宁,李红岩,韩晓云.加味杞菊地黄汤联合西药治疗子痫前期疗效及对患者外周血sFlt/PIGF和妊娠结局的影响[J].陕西中医,2021,42(9):1189-1192.
[4]蔡慧丽.血清sST-2、BNP和PAPP-A在妊娠高血压合并心力衰竭中预测妊娠不良结局的临床价值[J].临床荟萃,2020,35(2):139-143.
[5]娄秀芳.β-HCG,VB12及NEFA与妊娠期高血压疾病患者妊娠结局的相关性研究[J].现代实用医学,2023,35(9):1238-1240.
[6]王晓艳,李莲英.妊娠期高血压疾病与KIR、HLA-G的相关性研究[J].中国妇幼保健,2020,35(7):1194-1197.
[7]杨孜,张为远.《妊娠期高血压疾病诊治指南(2020)》解读[J].中华妇产科杂志,2020,55(6):8.
[8]谢幸,孔北华,段涛.妇产科学[M].第9 版.北京:人民卫生出版社,2018:147-150.
[9]中华医学会围产医学分会新生儿复苏学组.新生儿窒息诊断的专家共识[J]中华围产医学杂志,2016,19(1):3-6.
[10]AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS.Growth restriction:Acog practice bulletin,number 227[J].Obstet Gynecol,2021,137(2):e16-e28.
[11]POON L C,SHENNAN A,HYETT J A,et al.The international federation of gynecology and obstetrics (figo) initiative on pre-eclampsia:A pragmatic guide for first-trimester screening and prevention[J].Int J Gynaecol Obstet,2019,145(1):1-33.
[12]张丽,彭静,金璟,等.妊娠期高血压疾病孕妇血清和胎盘组织中血管内皮生长因子、糖基化终末产物、转化生长因子-β1表达及其与病情严重程度相关性研究[J].陕西医学杂志,2022,51(8):953-956,960.
[13]刘玉娟,彭拥花,林佩燕.PAPP-A在妇产科妊娠期高血压疾病发病中的应用[J].数理医药学杂志,2020,33(7):1004-1005.
[14]周立娜,张蕾,孙晓娜,等.妊娠期高血压疾病患者孕中期血小板参数、钙离子浓度、凝血指标与病情程度及母婴结局相关性研究[J].陕西医学杂志,2024,53(2):257-261.
[15]LI Q,SHARKEY A,SHERIDAN M,et al.Human uterine natural killer cells regulate differentiation of extravillous trophoblast early in pregnancy[J].Cell Stem Cell,2024,31(2):181-195.
[16]FAGALI FRANCHI F,DOS SANTOS P H,KUBO FONTES P,et al.PAPP-A enhances the antioxidative effects of IGF-1 during bovine in vitro embryo production[J].Theriogenology,2024,229:191-201.
[17]BLAAUWENDRAAD S M,WAHAB R J,VAN RIJN B B,et al.Associations of early pregnancy metabolite profiles with gestational blood pressure development[J].Metabolites,2022,12(12):1169.
[18]肖淑,余丽金,洪少和,等.妊娠期高血压疾病患者外周血PLGF,NEFA,Hcy水平的检测意义[J].中国性科学,2023(11):59-63.
[19]张莉梅,李林娜,王欢,等.狼疮抗凝物、抗心磷脂抗体、β2糖蛋白抗体联合检测对妊娠期高血压不良妊娠结局的预测价值[J].岭南心血管病杂志,2025,31(1):69-73.
[20]包向敏,张译心.孕早期产前筛查血清PAPP-A,β-HCG联合血清胎盘生长因子对妊娠期高血压患者妊娠结局的预测价值分析[J].实用预防医学,2023,30(10):1263-1266.
[21]XIAOYUN Z,CHUNXIA W .Predictive value of PAPP-A or ectopic pregnancy and analysis of related factors[J].Experimental and Therapeutic Medicine,2021,22(2):801.
[22]唐坎凯,梅丽娜.人白细胞抗原Ⅰ类分子在妊娠期高血压和子痫前期患者中的表达分析[J].中国妇幼保健,2020,35(12):2318-2322.
[23]LI D,DU H,WU N.Association between serum free fatty acids and gestational diabetes mellitus[J].Front Endocrinol (Lausanne),2024,15:1451769.
[24]陈亚玲,贺全勤,徐霞,等.miR-206、HLA-G以及GATA-3在妊娠期高血压患者血清和胎盘组织中的表达及意义[J].广东医学,2019,40(18):2623-2628.
[25]杨瑞,刘梅,张启明,等.血清NEFA、MPV及sFlt-1与妊娠期高血压疾病严重程度及病情进展的相关性分析[J].临床和实验医学杂志,2023,22(7):726-729.
[26]张璋,孙翠翠,黎晓曦.子痫前期患者血清妊娠相关血浆蛋白-A和血管内皮生长因子水平与妊娠结局的关系[J].新乡医学院学报,2023,40(2):140-145.